Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial - Kim, D-W; Tiseo, M; Ahn, M-J (J Clin Oncol, 2017)
et al.